RankAlpha logo
Back to Rankings

ACAD

ACADIAB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
ACAD vs peer average
68/100
ACAD vs. peer average (B vs. C)
Grade spread
A 1 · B 2 · C 2 · D 1 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

CRSP is the first available peer comparator.

Same-sector biotechnology comparator near ACAD’s market-cap range; useful for biotech risk-appetite context, but therapeutic and commercial overlap is not established.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerCRSPCRISPR Therapeutics
ACAD
ACADIA
CRSP
CRISPR Therapeutics
Grade
B
B
Momentum
71
66
Value
61
41
Sentiment
69
78
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs CRSP

ACAD / CRSP
Grade Position
In line
ACAD vs. peer average (B vs. C)
68/100
Momentum
71
ACAD
Value
61
ACAD
Sentiment
69
CRSP

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ACAD
1
CRSP
CRSP
B
80/100
Even
2
DYN
DYN
F
20/100
+3
3
EWTX
Edgewise Therapeutics Inc Common
D
40/100
+2
4
SHC
Sotera Health Co Common
B
80/100
Even
5
INDV
Indivior Pharmaceuticals Inc Common
C
60/100
+1
CRSP is the first peer returned for this comparison set.